This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral nature makes it valuable in the production of enantiomerically pure drugs, particularly those targeting the central nervous system. It is often employed in the development of medications for neurological disorders, such as Parkinson's disease and Alzheimer's disease, due to its ability to interact with specific neurotransmitter systems. Additionally, it serves as a building block in the creation of compounds with potential therapeutic effects in psychiatric conditions, including depression and anxiety. Its structural properties also make it a useful component in the design of ligands for receptor studies, aiding in the understanding of biochemical pathways and drug mechanisms.